Waiting for buywell to cheer me up with an over optimistic snippet of useless information |
Impressive - that's a lot of stock! |
Is appointing a new CFO great news when the company has no money to manage?Last CFO didn't last a year. More hot air and waffle pops. |
"things can only get better"
Been reading this for the last 20 odd years, ever since it was 60p a share. |
RNS update
Surgical Innovations Group plc (AIM: SUN), the designer, manufacturer and distributor of innovative medical technology for minimally invasive surgery ("MIS"), provides an update on trading for the year ended 31 December 2024, a period of turnaround which delivered a profitable second half and positions the Group for long-term growth.
Ref CMR previous posts
Over 29,000 surgical cases have now been completed using Versius globally, as CMR Surgical continues to bring the next-generation surgical robotic system to surgeons around the world. Versius resets expectations of robotic surgery
5 days ago
This means circa 3,000 procedures in 3 months or 12,000 in a year as of now regarding the 26,000 figure at end of November 2024.
IMO things can only get better as CMR procedures ramp up further as 2025 progresses
dyor |
Well! This is exciting..,,, |
900,000 shares traded off today!!! |
4.4M share trades out yesterday. Most traded in the first hour. Not exactly surging now and what news has prompted that downturn?Is it time to bail out? |
 --- The importance of CMR Surgical Versius robot to Surgical Innovations ---
Robotic surgical procedures achieving 22% growth on an annual basis, is IMO likely for CMR Surgical , with recent FDA approval it soon enters the US market.
AI Overview
The U.S. Food and Drug Administration (FDA) granted marketing authorization to CMR Surgical's Versius surgical robot on October 15, 2024:
Approval
The FDA granted de novo clearance for the Versius to perform minimally invasive gallbladder removal surgery on patients aged 22 and older.
Process
The FDA's de novo process is used to classify new medical devices that don't have a legally marketed equivalent.
Next steps
CMR Surgical plans to partner with a select number of hospitals in the U.S. before expanding nationwide.
Comparison to da Vinci
CMR Surgical believes its Versius system can compete with Intuitive's da Vinci, which has faced little competition in the past 20 years. CMR Surgical says the Versius is designed to be used in a range of surgical specialties and can be used in smaller hospitals.
The Versius is a portable, cart-based, laparoscopic robot with a compact design. It's the second most used surgical robotic system globally, with over 26,000 procedures completed in various regions.
da Vinci have just hit 22% annual growth in robotic surgical procedures
AI Overview
Robotic Surgery Statistics 2024 By - Procedures, Safety
In 2023, approximately 2,286,000 robotic surgical procedures were performed in the United States using da Vinci surgical systems. This was a 22% increase from 2022, when approximately 1,875,000 procedures were performed.
The United States is a global leader in robotic surgery, and many surgeons say that robotic systems can improve outcomes, reduce complications, and help patients recover more quickly.
CMR Surgical hit 10,000 milestone of robotic surgical procedures in March 2023 and then 20,000 milestone of robotic surgical procedures in March 2024
ie --- they performed 10,000 robotic surgical procedures in a 12 month period
If CMR Surgical can follow at 22% , then by March 2028 they will be able to perform 20,000 surgical procedures in a 12 month period.
Since Surgical Innovations manufacture ( and designed ) the port access device that the CMR Surgical Versius robot uses ( 4 of for most operations )
and also the optical trocar
Uncompromised field of view and peripheral vision, the YelloPort Elite™ Optical Trocar range provides optimal visualisation of the abdominal wall structures through its innovative design, whilst minimising plastic and the subsequent clinical waste generated from a Port Access System.
There are not only sales for these items when a Versius system ( 4 robotic arms ) is purchased by a Hospital BUT also ongoing spares sales (consumables ) for evry single surgical procedure that Versius then performs
ie
A new seal is required for each access port plus a replacement for the optical trocar ( used for camera viewing )
AI Overview
For an optical trocar used in surgery, the part that typically needs to be changed for each procedure is the obturator, which is the sharp, pointed tip that facilitates initial penetration through the tissue; this is because the tip can become dull or damaged during insertion and needs to be replaced to maintain effectiveness and minimize tissue trauma.
The cost of these items was IMO over 100 pounds circa 3 years ago , in 2025 more like 150 pounds ---- don't forget these are just consumables per surgical procedure
By March 2028 the cost for these spares will IMO have risen from current 150 pounds ( my estimate ) to 200 pounds.
Which means in consumables alone if CMR Surgical perform 20,000 surgical procedures in 2028 ,
Surgical Innovations earn
20,000 X 200 = 4 Million pounds
dyor |
LOL. buywell got its own thread at last, full of trip as usual :) |
From the header above
Can SUN rise again ?
free stock charts from uk.advfn.com
Is the recent CMR Surgical and Advanced Medical Solutions News BOTH regarding sales developments associated with Surgical Innovations designed AND still manufactured by Surgical Innovations , be starting to be realized by a few AIM investors ?
Jan 2nd 2025
free stock charts from uk.advfn.com |
It's that interesting that nothing has happened for weeks. Whole days with no trades. |
Thanks for this update Buywell, v interesting |
IMO in addition to the above post , buywell3 has omitted that CMR Surgical also utilizes the 5mm optical trocar made by Surgical Innovations in a significant portion of their operations
AI Overview
CMR Surgical Wins King's Award for Innovation
Yes, CMR Surgical and Surgical Innovations developed the YelloPort Elite 5mm surgical port access system.
The YelloPort Elite 5mm is a reusable trocar and cannula with a single-use valve that was designed for CMR Surgical's Versius surgical robot.
It can also be used with other laparoscopic instruments.
The YelloPort Elite 5mm was developed to reduce the cost and waste associated with traditional single-use surgical ports.
It was designed to minimize clinical waste and reduce costs for hospitals.
CMR Surgical is a surgical robotics company that aims to improve the quality of care for patients through robotics and minimal access surgery.
The CMR Surgical and Surgical Innovations co-developed YelloPort Elite 5mm system
AI Overview
According to available information, CMR Surgical utilizes the 5mm optical trocar made by Surgical Innovations in a significant portion of their operations, although the exact percentage is not publicly disclosed; however, it is considered a key component in many procedures performed with their Versius surgical robot due to its compatibility and features suitable for minimally invasive surgery.
Key points to consider:
No official percentage available:
CMR Surgical has not publicly stated the exact percentage of operations where they use the Surgical Innovations 5mm optical trocar.
Wide usage indicated:
Several sources mention the 5mm optical trocar as a commonly used component with the Versius system, suggesting a high usage rate.
Benefits of the trocar:
The 5mm optical trocar is likely preferred for its size and design, allowing for minimally invasive procedures with good visualization capabilities.
-----------------------------------
So for a large percentage of operations using the Versius robot made by CMR Surgical
AI Overview
Disposable Endoscopic Trocar Laparoscopic Surgery 5mm 10mm 12mm Trocars
For a 5mm optical trocar made by Surgical Innovations, the part that needs to be replaced after each operation is the obturator, which is the sharp, pointed tip used to initially penetrate the abdominal wall during insertion; the cannula (the hollow sleeve) and the optical component of the trocar are typically designed to be reusable, while the obturator is considered a disposable component.
Key points about the optical trocar:
Function:
An optical trocar allows the surgeon to directly visualize the tissue layers during insertion, minimizing the risk of injury, especially when creating the initial access port in laparoscopic surgery.
Components:
Cannula: The hollow tube that acts as the main body of the trocar.
Obturator: The sharp, pointed tip used to pierce the tissue and facilitate insertion.
Optical component: The part that provides the visual view during insertion.
---------------------------------
Conclusions:
As the number of installed CMR Versius Robots around the world ramps up so too will the number of operations performed
So too as the types of operations for which the Versius robot can be used .
Typically there are 4 Versius independent arms used in an operation
AI Overview
A typical operation using the CMR Surgical Versius surgical robot involves using all four of its robotic arms:
Number of arms:
The Versius has four arms
Arm configuration:
The Versius has a modular arm configuration
3D viewing:
The Versius uses passive 3D glasses
The Versius is a surgical robot that's attached to a mobile unit that's about the size of a barstool. The surgeon controls the robotic arms using finger and foot controls while looking through a high-definition monitor. The robot translates the surgeon's movements to guide each instrument in real-time.
Hence with every operation performed there are new valves required for the 3 X 5mm trocar instrument ports plus an obturator for the single 5mm optical trocar port
The numbers of these parts required for every operation are thus set to grow from this point going forwards
dyor |
In addition to the above, CMR Surgical utilizes the 5mm optical trocar made by Surgical Innovations in a significant portion of their operations
AI Overview
According to available information, CMR Surgical utilizes the 5mm optical trocar made by Surgical Innovations in a significant portion of their operations, although the exact percentage is not publicly disclosed; however, it is considered a key component in many procedures performed with their Versius surgical robot due to its compatibility and features suitable for minimally invasive surgery.
Key points to consider:
No official percentage available:
CMR Surgical has not publicly stated the exact percentage of operations where they use the Surgical Innovations 5mm optical trocar.
Wide usage indicated:
Several sources mention the 5mm optical trocar as a commonly used component with the Versius system, suggesting a high usage rate.
Benefits of the trocar:
The 5mm optical trocar is likely preferred for its size and design, allowing for minimally invasive procedures with good visualization capabilities.
-----------------------------------
So for a large percentage of operations using the Versius robot made by CMR Surgical
AI Overview
Disposable Endoscopic Trocar Laparoscopic Surgery 5mm 10mm 12mm Trocars
For a 5mm optical trocar made by Surgical Innovations, the part that needs to be replaced after each operation is the obturator, which is the sharp, pointed tip used to initially penetrate the abdominal wall during insertion; the cannula (the hollow sleeve) and the optical component of the trocar are typically designed to be reusable, while the obturator is considered a disposable component.
Key points about the optical trocar:
Function:
An optical trocar allows the surgeon to directly visualize the tissue layers during insertion, minimizing the risk of injury, especially when creating the initial access port in laparoscopic surgery.
Components:
Cannula: The hollow tube that acts as the main body of the trocar.
Obturator: The sharp, pointed tip used to pierce the tissue and facilitate insertion.
Optical component: The part that provides the visual view during insertion.
---------------------------------
Conclusions:
As the number of installed CMR Versius Robots around the world ramps up so too will the number of operations performed
So too as the types of operations for which the Versius robot can be used .
Typically there are 4 Versius independent arms used in an operation
AI Overview
A typical operation using the CMR Surgical Versius surgical robot involves using all four of its robotic arms:
Number of arms:
The Versius has four arms
Arm configuration:
The Versius has a modular arm configuration
3D viewing:
The Versius uses passive 3D glasses
The Versius is a surgical robot that's attached to a mobile unit that's about the size of a barstool. The surgeon controls the robotic arms using finger and foot controls while looking through a high-definition monitor. The robot translates the surgeon's movements to guide each instrument in real-time.
Hence with every operation performed there are new valves required for the 3 X 5mm trocar instrument ports plus an obturator for the single 5mm optical trocar port
The numbers of these parts required for every operation are thus set to grow from this point going forwards
dyor |
CMR Surgical look set to soon be carrying out several other procedures in the US
Mark Slack the co-founder and chief medical officer of CMR Surgical has very recently stated:
"we chose to go in the most efficient route possible, both financially and time-wise, which is to do a de novo and therefore only chose limited clinical indications.
The idea being, once we get that, we’ll then [submit 510(k) applications] on multiple other clinical scenarios.
We’ll start by upgrading the system, and then we’ll do colorectal, thoracic and all the other specialties, one after the other.
The real achievement was getting the system past a full FDA approval for the system and for all our instruments, because then doing the 510(k) is altogether much easier.
So we do small, limited clinical trials and expand it across to the other specialties here."
Google
AI Overview
On October 15, 2024, the U.S. Food and Drug Administration (FDA) granted marketing authorization for CMR Surgical's Versius surgical system:
What it means
The FDA's de novo clearance allows CMR Surgical to introduce the Versius robot in the U.S. for gallbladder removal procedures in patients aged 22 and up.
What it is
The Versius is a portable, cart-based, laparoscopic robot that assists surgeons with minimally invasive procedures:
It has collaborative arms and bedside units for direct patient access.
It offers port placement options to suit each patient's needs.
It's designed to biomimic the human arm.
How it works
The Versius can be wheeled around health facilities and put into place in about seven minutes. Surgeons can use it to do the entire procedure or parts laparoscopically.
Next steps
CMR Surgical plans to initially partner with a select number of U.S. hospitals before expanding nationwide. The company expects the total cost to be "favorable".
Other highlights
The Versius is the second most utilized surgical robotic system globally, with over 26,000 surgical procedures completed.
CMR Surgical & Surgical Innovations Develop New Surgical Hybrid Port Access System
CMR Surgical & Surgical Innovations develop new surgical hybrid port access system
• Surgical Innovations’ new YelloPort Elite™ 5mm, with reusable trocar and cannula, reduces cost and waste generated when compared with traditional fully single use Port Access Systems
• Developed with CMR Surgical, the port access system is the latest addition to Surgical Innovation’s Resposable® range of products and is designed specifically for the Versius® Surgical Robotic System
Cambridge, United Kingdom. 23 March 2022 00:01 (GMT). CMR Surgical – the global surgical robotics business – announces that it has worked with Surgical Innovations – a company specialising in the design, manufacture, sale and distribution of medical products – to develop YelloPort™ Elite 5mm, a new surgical port access system.
The surgical port is made up of a reusable trocar and cannula, with single use valve, which minimises clinical waste and reduces the cost for hospitals when compared to traditional single-use surgical ports(1).
YelloPort Elite™ 5mm was designed specifically for CMR’s surgical robot Versius®,though it is universal in nature and can be used in combination with a wider range of laparoscopic instrumentation.
YelloPort Elite™ 5mm received its CE Mark in February 2022 and will launch in Europe in April 2022 followed by a global rollout.
It is the first venture that Surgical Innovations and CMR Surgical have collaborated on.
David Marsh, Chief Executive Officer, Surgical Innovations, said: “We’re delighted to partner with CMR Surgical, a fellow British medical device company, to develop this new surgical Port Access System. Our ResposableTM products provide a high-quality hybrid instrument concept, with the clinical benefits of a small disposable element, reducing waste by at least 70% compared to fully disposable alternatives.”
Mark Slack, Chief Medical Officer, CMR Surgical, said: “When we talk to hospitals and clinical teams, we hear how important it is for them to reduce the environmental impact of the surgical products and instruments they use. We want to partner with hospitals to reduce waste and cost, whilst advancing performance. Working with Surgical Innovations to develop this new port, we’ve been able to do just that.”
In a typical Versius MIS operation 3 of the above trocars are used
After an operation the seals of each Trocar are removed and the Trocars sent for special hospital based cleaning procedure
Then new seals are fitted for the next patient --- Surgical Innovations make these seals .
So when Versius is installed at a new hospital in each country CMR Surgical are selling into --- the pace of which is increasing --- then that hospital has to hold and order new Trocars from Surgical Innovations plus spare seals ( 3 used per operation per patient )
During transaction involving ordering , Surgical Innovations sales people have the opportunity to showcase other MIS surgical instruments and products that they make , that also save a hospital money and reduce plastic waste together with a carbon footprint reduction.
The recent FDA clearance for Versius in the US , for Gallbladder removals thus presents the opportunity for the number of Versius operations to double IMO in 2025 IF CMR Surgical Sales can capture 1% of the market.
Google AI Question
how many MIS gallbladder removals in the US in 2023 ?
AI Overview
In the United States, surgeons perform around 1.2 million gallbladder removals each year, including: 605,000 ambulatory laparoscopic procedures, 280,000 inpatient laparoscopic procedures, and 49,000 inpatient open procedures.
The most common reason for gallbladder removal is repeated attacks of biliary colic. Gallbladder removal is often the safest and most effective treatment for symptoms or complications associated with gallbladder disorders.
The gallbladder is not an essential organ, and the body can adjust and function normally without it. However, surgery is usually carried out if you have painful gallstones, which can form in the gallbladder due to an imbalance in bile.
If you are experiencing symptoms of gallstones or think you are at risk for gallbladder disease, you should talk to your primary care provider about getting an ultrasound. Early detection of gallbladder disease can help save your life.
Amazing eh
Take Germany for example
how many MIS gallbladder removals in Germany 2023
AI Overview
According to available information, around 175,000 gallbladder removals are performed in Germany each year, making it one of the most common surgeries in the country due to the high prevalence of gallstone disease; most of these are likely to be minimally invasive (MIS) procedures
how many MIS gallbladder removals in France 2023
AI Overview
According to available research, in France, over 115,000 MIS (minimally invasive surgery) gallbladder removals, also known as cholecystectomies, are performed annually, primarily for symptomatic gallbladder stones; this data is considered fairly current and likely applies to 2023 as well.
See where I'm going
MIS Gallbladder removal is the most common MIS operation in the world
Google AI question
Is MIS gallbladder removal the most common operation in the world ?
AI Overview
Yes, minimally invasive gallbladder removal, also called a laparoscopic cholecystectomy, is considered one of the most common operations performed worldwide, making it a strong contender for the title of "most common operation" globally; this is primarily due to the high prevalence of gallstones, which often necessitate gallbladder removal
dyor |
October 15th 2024
Marketing Authorization for next-generation Versius Surgical System
Versius was granted marketing authorization through FDA’s De Novo process which establishes initial indication for adults undergoing cholecystectomy
24th November 2024
CMR Surgical is a global surgical robotics company. Its ground breaking next-generation surgical robot Versius performed its 20,000th surgical case in 2024.
The unicorn company’s small robot offers portability and unique design features that enable surgeons worldwide to provide minimal access surgery (MAS) to more people and across more specialities, such as thoracic surgery.
Over 75 per cent of hospitals that perform surgeries with Versius now use the system across at least two specialities, which has increased adoption uptake. Versius’s small V-wristed instruments and 3D HD vision support precise and accurate surgical performance across common- and complex elective procedures.
The robotic system biomimics the human arm with benefits such as optimised port placement, fully-wristed instruments that enhance dexterity and accuracy, and multiple ergonomic working positions — all of which can help reduce surgeons’ stress and fatigue and improve overall surgical efficacy. In 2023, CMR Surgical achieved over 50 per cent growth in its global install base.
In October 2024, CMR Surgical secured FDA approval for Versius in the US market. It now seeks to address the strong demand for surgical robotics across key territories including Asia Pacific, the Middle East and Africa, to help patients access optimal surgical care. CMR boasts the only global surgical robotics manufacturing facility in the UK.
Previously:
CMR Surgical announced that its Versius robot had performed over 10,000 cases on March 27th 2023
CMR Surgical announced on Sept 21st 2023 that its Verius robot had been used in more than 15,000 procedures across seven surgical specialties
Seems that with FDA approvals now coming 40,000 operations in 2025 is likely
Some related news from Surgical Innovations would perhaps IMO be welcomed by the market
dyor |
How dead can this stock get? One or two trades per day (if you're lucky).Come on SI, give us something positive!! |
I see HealthInvest AB sold their holding in August. It's on the RNS feed. They hold 0% now. |
Zombie company kept alive by repeated placings. Another one incoming. |
Placing coming. Directors not buying any stock. |
Well having just finished watching the presentation I feel more comfortable, sure there is risk but the team seem to have made good progress, interestingly especially in Israel & India, both being countries which could likely have companies who deal with SUN and could buy it up and scale up with a cash injection, imho. |
@ebitda
Precisely so, I was alrady signed up and await the webinar with interest ! |
Register to chat with like-minded investors on our interactive forums.
Hot Features
Premium
